Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from ES200301746Aexternal-prioritypatent/ES2222813B1/en
Application filed by Ferrer IntfiledCriticalFerrer Int
Publication of TNSN05325A1publicationCriticalpatent/TNSN05325A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
The present invention relates to compounds of Formula (I): wherein R1, R2 and R3 are as defined in the claims. The compounds have specific affinity for the GABAA receptor and are therefore useful in the treatment and prevention of diseases modulated by the alpha1- and alpha 2- GABAA receptors.
TNP2005000325A2003-07-242005-12-22N-[3-(3-SUBSTITUTED-PYRAZOLO[1,5-a]PYRIMIDIN-7-YL)PHENYL]-SULFONAMIDES, AND COMPOSITIONS, AND METHODS RELATED THERETO
TNSN05325A1
(en)
N-[3-(8-substituted-imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-sulfonamides, n-[3-(8-substituted-imidazo[1,5-a]pyrimidin-4-yl)-phenyl]-carboxamides, compositions, and methods related thereto